Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian Slomovitz
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- University of Arizona Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Jackson Memorial Hospital-Holtz Children'S Hospital
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- Bronson Battle Creek
Battle Creek, Michigan, United States
- Mercy Health Saint Mary'S
Grand Rapids, Michigan, United States
- Spectrum Health at Butterworth Campus
Grand Rapids, Michigan, United States
- Mercy Health Mercy Campus
Muskegon, Michigan, United States
- Lakeland Community Hospital
Niles, Michigan, United States
- Spectrum Health Reed City Hospital
Reed City, Michigan, United States
- Lakeland Hospital
Saint Joseph, Michigan, United States
- Marie Yeager Cancer Center
Saint Joseph, Michigan, United States
- Munson Medical Center
Traverse City, Michigan, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Cancer Research for the Ozarks Ncorp
Springfield, Missouri, United States
- Coxhealth South Hospital
Springfield, Missouri, United States
- Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
- Morristown Medical Center
Morristown, New Jersey, United States
- Overlook Hospital
Summit, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- Greenville Health System Cancer Institute-Faris
Greenville, South Carolina, United States
- Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- Carilion Clinic Gynecological Oncology
Roanoke, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jan 2012
- Primary completion
- 1 Jul 2022
- Completion
- —
- Last update posted
- 30 Sept 2021
- Registered enrollment
- 148
- Registry id
- NCT01500512
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.